Supply/Sourcing

(Editor’s note: This story is part of a recurring series of commentaries from professionals connected to the hemp industry. Julie Lerner is CEO of PanXchange, a commodity trading platform and benchmark price provider.) Basing the multibillion-dollar, pie-in-the-sky forecasts for the U.S. addressable market for CBD on retail shelf prices disturbs me. It’s as illogical as
0 Comments
RAMM Pharma, a cannabis-based pharmaceutical company with products in several Latin American countries, has bought a 49% stake in the Sicilian CBD processing company Canapar. Based in Toronto, RAMM purchased the shares from the cannabis venture-capital firm Canopy Rivers. Under the agreement, RAMM paid $7 million cash to Canopy Rivers to buy a little more
0 Comments